Sentences with phrase «complete program applications»

I can also help you complete program applications, submit required paperwork, answer legal questions, and troubleshoot bureaucratic problems related to student loan servicing.

Download and complete the program application.

Not exact matches

One such tool is Java, which is hailed as a complete programming language, with many features that are compatible with other applications.

Just use a service like Extole to create a referral system built into your application, complete with incentive programs and quality landing pages to drive new customers, all with minimal work on your end.

It's modeled on a popular computer programming technique called rapid application development, or RAD, which relies on prototyping and iterative improvements to complete a project.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

To sign up for this program, please complete the appropriate section of your account application.

To this end, it offers short - term Junior Research Fellowships on an ongoing basis to Canadians who are currently enrolled in undergraduate or master's - level programs, or who have completed their degree programs within 12 months of the application deadline.

To complete your application to the PhD program at the Rotman School of Management, you are required to provide documentation including a letter of intent, your CV, transcripts for all post-secondary institutions attended, two reference letters, GMAT or GRE scores, and TOEFL scores where applicable.

Prospective Innovation Entrepreneurs must lead organizations with annual revenues between $ 500K - $ 2 Million; organizations that have been fully operational for one year, but less than seven; and must complete the application below to be considered for the program.

Please contact Jodi Wilson ([email protected] or 415-356-7544) if you have any questions about the certification program or need assistance completing the application form.

Please visit www.rhinstitute.com to complete an application to join RHI's elite program.

Then, selected applicants are invited to participate in the Final Round Process that includes two mandatory elements — a more thorough application / review of the program and a completed survey component (Finalists are provided a link to a survey to have as many parents, coaches, volunteers, sponsors and anyone connected to their programs complete the online questionnaire).

Other Affiliated Organizations American Board of Pediatric Dentistry The American Board of Pediatric Dentistry is the organization which verifies to the public and health professions that a pediatric dentist has successfully completed both an advanced educational program accredited by the ADA Commission on Dental Accreditation and a voluntary examination process designed to validate the knowledge, application and performance requisite to the delivery of proficient care in pediatric dentistry

Complete applications should be sent as one PDF document in an email with the subject «Student Fellow Program Application'to [email protected].

Program details are still being finalized; complete application instructions and requirements are not yet available.

Complete nomination packages may be emailed to [email protected] with «Spectrum News NY1 Scholar Athlete Application» in the subject line, or sent via regular mail to Jessica Steiner, Spectrum News NY1, 75 9th Avenue, 6th Floor, New York, NY 10011, Attn: Spectrum News NY1 Scholar Athlete of the Week Program.

The measure also grandfathers any projects that complete 421 - a applications before the end of the year under the exiting program.

Click «Continue application» to move on to the next step and complete your application to the fellowship program.

All HPREP applicants must complete an application to both the HPREP program and Johns Hopkins Medical Institutions Human Resources Department.

«My department made available to me during the application and admission process the percentage of students who complete the program»

While completing the application, facilities are required to identify and correct potential problems, revising protocols and validating quality assurance programs.

Rolling admissions will begin in March, for applicants who meet program requirements, submit completed application materials, and pay tuition deposit.

For example, panelists evaluating applications submitted to the Graduate Research Fellowship Program may consider the following with respect to the Intellectual Merit Criterion: the potential of the applicant to advance knowledge based on a holistic analysis of the complete application, including the Personal, Relevant Background, and Future Goals Statement, Graduate Research Plan Statement, strength of the academic record, description of previous research experience or publication / presentations, and references.

The talents of many people are needed to successfully complete such programs, requiring the application of management approaches and tools appropriate to projects of such scale.

Applications are open to students in Bachelor's and Master's degree programs in any subject area; Bachelor students must have completed at least two academic years at the start of the scholarship period.

Once you complete the application, we'll schedule a short call and discuss if the apprenticeship program is right for you.

In order for you to fully benefit from the practical application lessons taught by Dr. Kalish, it is important that you practice by communicating the techniques with your patients, test them, test yourself, and implement any recommended lifestyle changes if you are in the mentorship program, or complete the business plan and all other worksheet assignments in the My Practice Plan course.

We have submitted an application to IAYT for accreditation of our yoga therapy program, and will be able to provide information on our status after IAYT completes our review.

If you do not meet the Path 1 criteria and believe you are a good fit for the program, you may petition for admission by completing the petition section of the application.

As part of the program, students complete job applications, practice interviewing, and critique workplace attire in order to ensure that they «dress for success.»

In 2003 the program received more than 1,000 completed applications for just 55 spots.

Providers can attain the «endorsed» title if they've run programs in the past, met certain quality benchmarks (such as maintaining minimum enrollment and retention numbers), participate in PASA's quality - assessment process, and completed the Endorsed AfterZone Program Application.

AfterZone program grants are distributed to providers that complete an AfterZone Program Funding Application and qualify to run a program within the Aftprogram grants are distributed to providers that complete an AfterZone Program Funding Application and qualify to run a program within the AftProgram Funding Application and qualify to run a program within the Aftprogram within the AfterZone.

All applicants must complete all three Phases of the certification program by the time they submit their application.

Unofficial transcripts do not need to be resubmitted during the application process unless new courses were taken or a new degree program was completed.

Parents who wish to enroll their children in a private or religious school participating in the statewide voucher program for the 2016 - 17 school year must complete the online application between February 1 and April 20, 2016, on the following web site: http://dpi.wi.gov/SMS/choice-programs/student-applications.

Yu Ying, which recently held its third annual enrollment lottery to process 500 applications for 100 spaces, is just one illustration of the invaluable service that CSDC's fee developer program provides to successful, expanding charter schools that recognize the benefits of outsourcing their facility needs to an experienced developer on a complete, «turnkey» basis.

This recorded PowerPoint provides information on the overall Title II, Part A, program, including intended uses of funds, updates about teacher quality provisions, and general requirements of school divisions under Title II, Part A. Additionally, the presentation provides information about the overall application process for Title II, Part A, including general provisions, needs assessment, and completing the program specific pages of the application.

Schools applying for one of the awards will be required to submit a completed application along with supporting evidence to South Carolina ASCD according to program timelines.

An employee's participation in the optional retirement program commences on the first day of the next full calendar month following the filing of the election and completed application with the program administrator and receipt of such election by the department.

This document outlines the essential tools you'll need to successfully complete portions of your application for the U.S. Department of Education's Green Ribbon Schools voluntary recognition program.

An employee's participation in the optional retirement program commences retroactive to the first day of qualifying employment following the filing of the election and completed application with the program administrator and receipt of such election by the department.

Program graduates are eligible for free tutoring, SAT preparation sessions, and one - on - one mentoring to help complete college applications.

These documents relate to our commitment to the student nutrition program Instructions for completing the household application Instructiones en Espanol 2017 - 2018 Income Eligibility Table 2017 - 2018 Comidas Gratis O A Reducido Applicacion en Espanol 2017 - 2018 Free and Reduced Lunch Application in English Amy Biehl High School does not discriminate on the basis of race, color, national... Contiapplication Instructiones en Espanol 2017 - 2018 Income Eligibility Table 2017 - 2018 Comidas Gratis O A Reducido Applicacion en Espanol 2017 - 2018 Free and Reduced Lunch Application in English Amy Biehl High School does not discriminate on the basis of race, color, national... ContiApplication in English Amy Biehl High School does not discriminate on the basis of race, color, national... Continue Reading

Application for admission to the School Counseling program must be completed online through the Office of Admission.

All individuals who wish to earn a Texas teacher license and become a classroom teacher must earn a bachelor's degree, complete an approved educator preparation program, pass a certification exam for the area they will be teaching, submit a state application, and submit to fingerprinting, according to the Texas Education Agency.

There are five basic requirements for becoming certified to teach in Texas: hold a bachelor's degree, complete an educator preparation program, pass the appropriate certification exams, complete the application process, and be fingerprinted as part of a criminal background check.

Got questions about how to complete the latest Public Charter Schools Grant Program application?

CCSA's Knowledge Management Team will be offering one - hour consultations on September 12th through 16th for any Member School that has questions related to completing the Public Charter Schools Grant Program (PCSGP) application.